Turnkey CDMO Partner

From Concept to
Commercialization

End-to-end drug-device combination solutions for insulin pen

manufacturers - industrial design, patent strategy, mold

development, aseptic filling, automated assembly, and global

regulatory support.

 

Explore Services →     Contact Us

 

 
8

End-to-End Steps

 
45

Days to First Mold

 
±0.5%

Filling Accuracy

 
300

PPM Assembly Speed

 

End-to-End Capabilities

Our 8-Step Turnkey Process

01 Industrial & Structural Design

User-centric ergonomic design focusing on low injection force, clear dose display, and comfortable grip. Covers both disposable and reusable pen platforms.

 


 

ISO 11608-1 3D Prototyping ID/MD Design

02 Patent Strategy & FTO Analysis

Comprehensive Freedom-to-Operate (FTO) analysis across US, EU, and key Asian markets. We design around existing patents to ensure clean market entry.

 


 

USPTO Search EPO Analysis Design-Around

S136 steel molds guaranteed for ≥1,000,000 shots. 32–64 cavity tooling with Husky/Yudo hot runner systems. All production in ISO Class 8 cleanrooms.

 


 

S136 Steel 64-Cavity ISO Class 8

04 Component Injection Molding

Full-scale production of all pen components - pen body, dose dial, cartridge holder, needle cap - with 100% dimensional inspection and traceability.

 


 

Medical Grade 100% Inspection GMP Cleanroom

05 Aseptic Filling (Insulin & GLP-1)

Isolator-based aseptic filling for insulin, , and other GLP-1 drugs. Ceramic pump systems achieving ±0.5% accuracy at up to 600 CPM.

 


 

±0.5% Accuracy 600 CPM SAL 10⁻⁶

06 Automated Pen Assembly Line

Cam-driven continuous motion assembly achieving 60–300 PPM. Integrated Keyence/Cognex vision inspection, torque testing, and 21 CFR Part 11 SCADA.

 


 

300 PPM Vision Inspection 21 CFR Part 11

07 Drug-Device Final Assembly

Precision cartridge integration, snap-fit locking, GS1 DataMatrix serialization, and cold-chain ready secondary packaging - all in GMP Class C/D.

 


 

Track & Trace GS1 DataMatrix Cold Chain

08 GMP / FDA Compliance & Regulatory

Complete validation documentation (DQ/IQ/OQ/PQ), GAMP5 CSV support, and assistance with FDA 510(k), NDA, and CE MDR submission dossiers.

 


 

ISO 13485 EU MDR FDA 510(k)

 

Aseptic Filling

Insulin & GLP-1
Drug Filling

 

Our isolator-based aseptic filling lines handle insulin, (Ozempic/Wegovy generics), and other GLP-1 biologics with the highest sterility assurance levels required for injectable drug products.

±0.5%

Filling Accuracy

600 CPM

Output Speed

SAL 10⁻⁶

Sterility Level

ISO Class 5

Environment

page-960-535

 

page-960-535

Mold Development

High-Precision
Injection Molds

 

From concept to T1 sample in as little as 45 days. Our S136 steel molds are engineered for medical-grade precision and guaranteed for over one million shots, ensuring long-term production reliability.

 

  S136 steel with ≥1,000,000 shot guarantee

  32 to 64-cavity with Husky/Yudo hot runners

  ISO Class 8 cleanroom production

  Full mold flow analysis (Moldflow) before cutting

  Lifetime mold warranty included

 

Competitive Advantages

Why Choose DROFEN?

8 Steps, 1 Partner

One-Stop Integration

Seamless execution from industrial design to final assembly, eliminating multi-vendor coordination risk.

30–50% Savings

Cost Efficiency

Leveraging China's precision manufacturing ecosystem to deliver 30–50% cost savings vs. European competitors.

45-Day Molds

Speed to Market

Rapid prototyping and mold development in as little as 45 days to accelerate your product launch timeline.

FDA + CE + ISO

Compliance Ready

Full adherence to FDA 21 CFR Part 4/11 and ISO 11608 with complete validation documentation packages.

Zero IP Risk

Innovation & FTO

Expert patent analysis and design-around strategies to ensure Freedom-to-Operate in all target markets.

24/7 Support

Global Support

On-site installation, operator training, and 24/7 remote technical support to ensure continuous operation.

 

Regulatory Excellence

GMP / FDA
Compliance Ready

 

We don't just build equipment - we deliver complete compliance packages. Our validation documentation, facility design, and regulatory support services are designed to help your product pass audits on the first attempt.

 

FDA

COMPLIANT

CE MDR

COMPLIANT

ISO 13485

COMPLIANT

Standards We Support

 

FDA 21 CFR Part 4 (Combination Products)

FDA 21 CFR Part 210/211

ISO 11608-1 (Needle-based Injection Systems)

ISO 13485:2016

GAMP 5 (Computer System Validation)

EU MDR 2017/745

21 CFR Part 11 (Electronic Records)

ICH Q10 (Pharmaceutical Quality System)

Proven Results

Success Stories

Europe · Poland

Top 5 Generic Pharma


 

Challenge

Needed a fully automated EU GMP-compliant assembly line within 8 months to beat competitors to market.

 

Solution

Delivered a 12,000 UPH line with integrated vision inspection and auto-packaging, validated to PQ.

 

Result

Launched 1 month early; reduced labor costs by 80%.

 


 

"The speed and precision of Drofen's line exceeded our expectations. A true partner."

Asia · India

Leading Biotech Co.


 

Challenge

Developing a generic pen but faced severe patent barriers from originators in key markets.

 

Solution

Provided a complete 'Design-Around' mechanism with comprehensive FTO clearance for US and EU.

 

Result

Secured market entry with zero IP litigation risks.

 


 

"Their patent expertise saved us millions in potential legal risks."

Americas · Brazil

Emerging Pharma Group


 

Challenge

Greenfield insulin plant project with no prior drug-device combination manufacturing experience.

 

Solution

Full Turnkey Service: factory layout, equipment supply, validation (PQ), SOPs, and operator training.

 

Result

Operational in 8 months; passed ANVISA audit on first attempt.

 


 

"Drofen didn't just sell machines - they taught us how to manufacture."

 

Market Entry

EU & US Market Entry
Strategies

 

🚩

Direct Market Entry

Build your own brand and sales channels in target markets. Highest margin, full brand control.

  Highest profit margin

  Full brand ownership

  Long-term asset value

🤝

Distributor Partnership

Partner with established local pharmaceutical distributors for rapid market access.

  Faster time-to-market

  Lower marketing cost

  Shared regulatory risk

📄

Out-Licensing

License your product IP and manufacturing rights to major pharma companies for royalties.

  Immediate revenue

  Minimal commercial risk

  Focus on R&D/production

 

Contact with us
Have questions? Feel free to write us

Thank you for your interest in our company. For more information about our products, services and pricing, please fill out the form below and a DROFEN representative will contact you shortly.